Core Laboratories (CLB) Total Current Liabilities (2022 - 2026)

Core Laboratories' Total Current Liabilities history runs 5 years deep, the most recent figure standing at $104.7 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 0.97% year-over-year to $104.7 million in Q1 2026; TTM through Mar 2026 was $104.7 million, a 0.97% increase from a year earlier, with the FY2025 full-year figure at $106.0 million, up 3.48% from the prior year.
• Total Current Liabilities slipped to $104.7 million in Q1 2026 per CLB's latest filing, from $106.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $106.0 million in Q4 2025 and bottomed at $84.2 million in Q3 2023.
• The 5-year median for Total Current Liabilities is $97.6 million (2024), against an average of $97.5 million.
• Across the five-year window, Total Current Liabilities declined 14.58% in 2023 and gained 21.36% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $103.1 million in 2022, then slipped by 14.58% to $88.1 million in 2023, then grew by 16.29% to $102.4 million in 2024, then gained by 3.48% to $106.0 million in 2025, then fell by 1.21% to $104.7 million in 2026.
• Per Business Quant, the three latest CLB Total Current Liabilities figures stand at $104.7 million (Q1 2026), $106.0 million (Q4 2025), and $95.7 million (Q3 2025).